By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Ruthigen, Inc. (Form 10-K) was posted on June 30, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 11 documents filed with this form. The SEC file number is 0001144204-14-040451.
The contact information for this company is 2455 BENNETT VALLEY RD. SUITE C116, SANTA ROSA CA 95404, (707) 525-9900.
Our editors provided additional information about Form 10-K: This is the annual report that most reporting companies file with the Commission. It provides a comprehensive overview of the registrant’s business. The report must be filed within 90 days after the end of the company’s fiscal year.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1574235/0001144204-14-040451-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Ruthigen Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC